论文部分内容阅读
许多儿科危重症都可并发弥漫性血管内凝血(DIC)而使病情恶化导致死亡。使用肝素治疗 DIC 已得到理论和临床上的证实。由于儿科患者病情变化快,基层医院化验检查设备不完善等。给 DIC 的诊断和肝素的应用带来许多困难。为及时制止 DIC 的发生和发展,有人主张在 DIC 早期血液处于高凝状态时应用肝素,认为凡确诊为感染性休克者,均应常规做试
Many pediatric critical illness can be complicated by diffuse intravascular coagulation (DIC) that worsens the condition leading to death. The use of heparin to treat DIC has been confirmed theoretically and clinically. Due to rapid changes in pediatric patients, primary hospital laboratory testing equipment is not perfect. DIC diagnosis and the use of heparin brings many difficulties. In order to stop the occurrence and development of DIC in a timely manner, some people advocate the application of heparin in the early stage of DIC when the blood is hypercoagulable, and all those who are diagnosed as septic shock should do routine test